ASPIRE kickstarted the inaugural edition of the Lung Cancer Care Continuum Policy Forum Series: An Evidence Review on Local Scientific & Clinical Effort in Hong Kong at the Renaissance Hong Kong Harbour View Hotel on September 24, 2024.
The event brought together leading lung cancer experts from various specialties to share their latest research and findings, with a strong emphasis on prevention and screening. In this first edition, discussions provided valuable insights into effective strategies for early detection, highlighting its critical role in improving patient outcomes. The exchange of knowledge and expertise at this event will significantly shape future practices in lung cancer care in Hong Kong.
We extend our gratitude to the following experts from the Chinese University of Hong Kong (CUHK), The University of Hong Kong (HKU), various private practitioners and cancer patient groups for their invaluable contributions to the success of this event. Their engagement and expertise are vital in driving progress in this field:
Prof. Tony Mok, Prof. Martin Wong, Assoc. Prof. Herbert Loong, Prof. Rina Hui, Assoc. Prof. David Lam, Assoc. Prof. Yin Ting Cheung, Assist. Prof. Derek Cheung, Assist. Prof. Jacky Lam, Assist. Prof. Molly Li, Dr. Alan Sihoe, Dr. Vince Varut Vardhanabhuti, Dr. Johnny Lau, Dr. Joseph Au, Mr. Alex Yam, Ms. Katy Tong
As we look ahead to the next edition, we are committed to exploring essential topics throughout the entire patient journey and facilitating discussions among key experts to reach a consensus on best practices in lung cancer care and management. At ASPIRE, we are committed to fostering a collaborative, multilateral approach to drive change across the patient care continuum, with a focus on improving patient access to care and outcomes.
Follow us on LinkedIn to stay updated, and please reach out with any questions or to learn more.
We would like to extend our sincere thanks to our industry partners, MSD and Roche Diagnostics, for their support and contribution for making this roundtable possible.
We are a collaborative multilateral effort focused on improving lung cancer outcomes in the Asia-Pacific region through policy reforms.
